SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-24-063802
Filing Date
2024-03-08
Accepted
2024-03-08 17:21:26
Documents
7

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d808981dsc14d9.htm SC 14D9 600339
2 EX-99.(E)(4) d808981dex99e4.htm EX-99.(E)(4) 133005
3 EX-99.(E)(5) d808981dex99e5.htm EX-99.(E)(5) 312633
4 EX-99.(E)(6) d808981dex99e6.htm EX-99.(E)(6) 162430
5 EX-99.(E)(12) d808981dex99e12.htm EX-99.(E)(12) 16719
6 GRAPHIC g808981g02a36.jpg GRAPHIC 26212
7 GRAPHIC g808981g02a40.jpg GRAPHIC 33628
  Complete submission text file 0001193125-24-063802.txt   1303342
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filed by) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Subject) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-90978 | Film No.: 24735640
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)